Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.06 USD | +0.40% |
|
-0.43% | -2.87% |
18/06 | Haemonetics Corporation Launches Limited Market Release of its New VASCADE MVP XL Mid-Bore Venous Closure Device | CI |
12/06 | Haemonetics Shares Rise After Upgrade From Needham | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.87% | 4.23B | |
-6.24% | 180B | |
-6.08% | 99.21B | |
-5.98% | 66.25B | |
-9.35% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.88% | 28.98B | |
-8.38% | 23.5B | |
+16.18% | 24.07B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Transcript : Haemonetics Corporation Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 10